Teresa Jones, M.D.
Responsibilities & Activities
I am the project scientist for the Diabetic Foot Consortium that develops and tests biomarkers for diabetic foot ulcers; the program officer for the Cardiovascular Repository for Type 1 Diabetes (CARE-T1D); the program director for studies on the safe use of sodium-glucose co-transporter 2 inhibitors (SGLT2i) in type 1 diabetes; and the NIDDK project scientist for the Trial to Assess Chelation Therapy 2 (TACT2) trial.
Research Programs
Diabetes: Treatment, Prevention, & Complications
The Diabetes: Treatment, Prevention, and Complications Program supports both basic and clinical studies aimed at addressing the prevention, treatment and pathophysiology of type 1 and type 2 diabetes across the lifespan.
Committees & Working Groups
Select Experience
Investigator, Intramural Research Program, NIDDK, NIH, 1995-2003
Fellowship - Board Certified in Endocrinology and Metabolism, NIH, 1987-1989
Residency - Board Certified in Internal Medicine, University of Minnesota, 1983-1986
M.D., Northwestern University Honors Program in Medical Education, 1983